Reference
Harrigan K, et al. Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine for Tardive Dyskinesia. 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PMH29, 19 May 2018. Available from: URL: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/80237?pdfid=54665
Rights and permissions
About this article
Cite this article
Valbenazine, deutetrabenazine costly for tardive dyskinesia. PharmacoEcon Outcomes News 805, 34 (2018). https://doi.org/10.1007/s40274-018-5036-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5036-6